PMGC Holdings Inc. (NASDAQ:ELAB) Sees Significant Decline in Short Interest

PMGC Holdings Inc. (NASDAQ:ELAB) was the target of a large decline in short interest during the month of February. As of February 27th, there was short interest totaling 86,753 shares, a decline of 33.0% from the February 12th total of 129,521 shares. Approximately 2.7% of the company’s stock are sold short. Based on an average daily trading volume, of 1,370,775 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 1,370,775 shares, the days-to-cover ratio is presently 0.1 days. Approximately 2.7% of the company’s stock are sold short.

PMGC Stock Up 4.1%

ELAB traded up $0.18 during trading on Friday, hitting $4.58. 57,294 shares of the stock were exchanged, compared to its average volume of 154,341. PMGC has a 1-year low of $3.97 and a 1-year high of $686.28. The stock has a fifty day moving average price of $14.65 and a two-hundred day moving average price of $81.46. The firm has a market capitalization of $2.47 million, a P/E ratio of -0.07 and a beta of 1.12.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, PMGC presently has a consensus rating of “Sell”.

About PMGC

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.